Compare stocks

BIAF vs STEX

bioAffinity Technologies, Inc. Common Stock and Streamex Corp. Common Stock

Compare the businesses

bioAffinity Technologies, Inc. Common Stock

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

Open BIAF dashboard ↗

Streamex Corp. Common Stock

Streamex Corp., a real world asset (RWA) tokenization company with Institutional grade infrastructure. It offers gold denominated treasury and tokenization technology to commodities markets. The company was formerly known as BioSig Technologies, Inc. and changed its name to Streamex Corp. in September 2025. Streamex Corp. was incorporated in 2009 and is based in Winter Park, Florida.

Open STEX dashboard ↗

Sign in to keep comparing stocks

You've viewed 3 distinct stock or comparison pages today. Sign in for 10 views per day.

3 of 3 daily views used. Your allowance resets at midnight Eastern time. Refreshes and chart changes do not use another view.

New to NexusTrade? Create a free account.

Choose another comparison ↗